Search

everythinglearnresearchcommunity

for

Search:↓

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Both genetic and lifestyle factors significantly affect female hair loss.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Men prefer less invasive cosmetic procedures and need different treatment approaches than women.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Ruby laser hair removal significantly reduces hair density.

Red clover extract improved hair, skin, mood, sleep, and tiredness in postmenopausal women.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Hair loss in postmenopausal woman caused by ovarian issue.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Frontal fibrosing alopecia and androgenetic alopecia may be related, with a possible shared cause.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

EF and PXE not closely related.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Hair transplantation is the only permanent solution for female pattern hair loss and can greatly improve quality of life with careful planning.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Statins may be linked to reproductive organ conditions, and their risks should be monitored.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

The document concludes that awareness and understanding of hidradenitis suppurativa are increasing, but effective treatments are still needed.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.